상세 컨텐츠

본문 제목

ENG, Antiobesity Medications for Weight Loss, 비만치료제, 살빼는 약, T832

건강 health/=약 Drug medication

by 진보남북통일 2024. 7. 26. 13:53

본문

ENG, Antiobesity Medications for Weight Loss, 비만치료제, 살빼는 약,

 

File attached;

2 AntiObesity Weight Loss 비만 치료제.docx
0.01MB

 

List of Common Weight Loss Drugs;

https://www.drugs.com/condition/obesity.html?page_all=1&sort=drug&order=asc

 

List of Medications for Weight Loss (Obesity/Overweight)

Compare risks and benefits of common medications used for Weight Loss (Obesity/Overweight). Find the most popular drugs, view ratings and user reviews.

www.drugs.com

 

-------------

when was mounjaro or zepbound released in market?

in spring 2022, FDA approved Mounjaro (tirzepatide) for use in the United States to treat type 2 diabetes.

In November 2023, FDA approved a new version of Mounjaro, called Zepbound, for use as a weight loss drug.

------------

What company makes Mounjaro (tirzepatide), Zepbound?

Lilly is the only lawful supplier of FDA-approved tirzepatide medicines—Mounjaro ® and Zepbound ® and does not provide tirzepatide (active ingredient in Mounjaro ® and Zepbound ®) to compounding pharmacies, med-spas, wellness centers, online retailers, or other manufacturers. Jun 20, 2024

Novo Nordisk’s Ozempic, Wegovy and Eli Lilly’s Mounjaro and Zepbound,

 

^^What are the ingredients in tirzepatide?

Active ingredient: tirzepatide Inactive ingredients: sodium chloride, sodium phosphate dibasic heptahydrate, and water for injection. Hydrochloric acid solution and/or sodium hydroxide solution may have been added to adjust the pH

-------------

Tirzepatide (active ingredient in Mounjaro ® and Zepbound ®)

side effects;

-Abdominal pain, -Vomiting, -Constipation, -Diarrhea, -Allergic reactions, -Fatigue,

-Injection site reaction, -Blurred vision, -Gallbladder problems, -Indigestion, -Bloating,

-Tachycardia(심박 급속증-心拍急速症, 심계 항진), -Hypersensitivity, -Confusion,

-Anorexia(신경성 식욕 부진증, 거식증), -Hunger, -(1% to 10%): hyperglycemia, -Belching,

 

MOUNJARO has been associated with gastrointestinal adverse reactions, which include nausea, vomiting, and diarrhea [see Adverse Reactions (6.1)]. These events may lead to dehydration, which if severe could cause acute kidney injury.

 

Does Zepbound cause kidney issues?

Zepbound can cause serious side effects, including: Kidney problems (kidney failure).

Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems.

--------------

Zepbound side effects; pdf 3P,

https://pi.lilly.com/us/zepbound-us-mg.pdf

-----------

;Mounjaro(tirzepatide) side effects,

https://www.drugs.com/medical-answers/mounjaro-side-effects-you-need-aware-3576835/

 

7 Mounjaro side effects you need to be aware of

Official answer: Key Points The most common Mounjaro side effects to be aware of are diarrhea, vomiting, constipation, nausea (mild to...

www.drugs.com

 

 

Common side effects of Mounjaro (tirzepatide) include nausea, vomiting, and fatigue.

In some severe cases, Mounjaro may also cause stomach paralysis.

 

The most common side effects of Zepbound include abdominal pain, burping, nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, dyspepsia, fatigue, injection site reactions, gastroesophageal reflux disease, feeling tired, allergic reactions, belching, hair loss, and heartburn. hypersensitivity reactions, injection site reactions,

------

;Zepbound and Mounjaro(tirzepatide) price;

Mounjaro (tirzepatide) is typically priced between $1,020 to $1,200 per month before insurance,

while the out-of-pocket cost for Zepbound is listed at $1,060 per month.

------

Are Zepbound and Mounjaro(tirzepatide) the same?

Zepbound and Mounjaro share the same active ingredient, tirzepatide.

The main difference between Zepbound vs. Mounjaro is that they are FDA-approved to treat different health conditions. 

Zepbound is indicated for weight loss, while

Mounjaro(tirzepatide) is indicated for type 2 diabetes. May 6, 2024,

 

관련글 더보기